Elin Kindstedt

Dr. Elin Kindstedt

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2018 in Journal of Periodontology
Verified
Journal Article
Closed access
PDF file
EKElin Kindstedt
Elin Kindstedt
CHCecilia Koskinen Holm
Cecilia Koskinen Holm
PPPy Palmqvist
Py Palmqvist
MSMats Sjöström
Mats Sjöström
KLKristina Lejon
Kristina Lejon
PLPernilla Lundberg
Pernilla Lundberg

15 February 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CVCharlotte de Vries
Charlotte de Vries
GRGuillermo Ruacho
Guillermo Ruacho
EKElin Kindstedt
Elin Kindstedt
BPBarbara Aleksandra Potempa
Barbara Aleksandra Potempa
JPJan Potempa
Jan Potempa
KLKarin Lundberg
Karin Lundberg
There is accumulating data suggesting that periodontitis is associated with increased risk of systemic and autoimmune diseases, including cardiovascular disease, rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), and there is an unmet need to identify these individuals early. With the periodontal bacteria Porphyromonas gingivalis (Pg) as one of the key drivers of periodontitis, we set out to investigate whether antibodies to Pg virulence factor arginine gingipain (Rgp) could serve as a biomarker for periodontitis patients at increased risk of autoimmunity and systemic disease. We measured serum anti-Rgp IgG in three study populations: PAROKRANK (779 individuals with myocardial infarction (MI); 719 controls), where 557 had periodontitis, and 312 were positive for autoantibodies associated with RA/SLE; the PerioGene North pilot (41 periodontitis; 39 controls); and an SLE case/control study (101 SLE; 100 controls). Anti-Rgp IgG levels were increased in severe periodontitis compared to controls (p < 0.0001), in individuals positive for anti-citrullinated protein antibodies (p = 0.04) and anti-dsDNA antibodies (p = 0.035), compared to autoantibody-negative individuals; and in MI patients versus matched controls (p = 0.035). Our data support longitudinal studies addressing the role of anti-Rgp antibodies as biomarkers for periodontitis patients at increased risk of developing autoimmunity linked to RA and SLE, and mechanisms underpinning these associations.

1 January 2021 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SRSara Rosendahl
Sara Rosendahl
RSRima Sulniute
Rima Sulniute
MEMichaela Eklund
Michaela Eklund
CHCecilia Koskinen Holm
Cecilia Koskinen Holm
MJMarcus J.O. Johansson
Marcus J.O. Johansson
PLPernilla Lundberg
Pernilla Lundberg
Increasing evidence emphasizes the importance of chemokines and chemokine receptors as regulators of bone remodeling. The C–C chemokine receptor 3 (CCR3) is dramatically upregulated during osteoclastogenesis, but the role of CCR3 in osteoclast formation and bone remodeling in adult mice is unknown. Herein, we used bone marrow macrophages derived from adult male CCR3-proficient and CCR3-deficient mice to study the role of CCR3 in osteoclast formation and activity. CCR3 deficiency was associated with formation of giant hypernucleated osteoclasts, enhanced bone resorption when cultured on bone slices, and altered mRNA expression of related chemokine receptors and ligands. In addition, primary mouse calvarial osteoblasts isolated from CCR3-deficient mice showed increased mRNA expression of the osteoclast activator–related gene, receptor activator of nuclear factor kappa-B ligand, and osteoblast differentiation–associated genes. Microcomputed tomography analyses of femurs from CCR3-deficient mice revealed a bone phenotype that entailed less cortical thickness and volume. Consistent with our in vitro studies, the total number of osteoclasts did not differ between the genotypes in vivo. Moreover, an increased endocortical osteoid mineralization rate and higher trabecular and cortical bone formation rate was displayed in CCR3-deficient mice. Collectively, our data show that CCR3 deficiency influences osteoblast and osteoclast differentiation and that it is associated with thinner cortical bone in adult male mice.

13 December 2023 in Journal of Periodontology
Verified
Journal Article
Open access
ADAhed Dyab
Ahed Dyab
AEAva Emnegard
Ava Emnegard
MWMagnus Wänman
Magnus Wänman
FSFilippa Sjöström
Filippa Sjöström
EKElin Kindstedt
Elin Kindstedt
Background: Host‐modulating therapy is a possible treatment for individuals that respond poorly to conventional periodontal therapy. B cells, abundant in periodontitis lesions, require the cytokines B cell‐activating factor (BAFF) and A proliferation‐inducing ligand (APRIL) for survival and maturation. Although mRNA levels of BAFF and APRIL are increased in tissue from periodontitis lesions, it is unknown if periodontal resident cells express BAFF and/or APRIL during periodontal inflammation. In this study, we aim to analyze the expression of BAFF and APRIL in human gingival fibroblasts after stimulation with proinflammatory cytokines. Furthermore, we perform protein analysis in tissues and serum from periodontitis patients and healthy controls.Methods: Human gingival fibroblasts were cultured and stimulated with the proinflammatory cytokines’ tumor necrosis factor‐alpha (TNF‐α) and interleukin‐1 beta (IL‐1β). The mRNA expression of BAFF and APRIL was analyzed by real‐time quantitative polymerase chain reaction (qPCR), and the protein was detected in tissue sections using immune staining. Serum levels of BAFF were analyzed with enzyme‐linked immunosorbent assay (ELISA).Results: In gingival fibroblasts, TNF‐α upregulated BAFF mRNA, but APRIL was unaffected. IL‐1β affected neither BAFF nor APRIL expression. BAFF protein was detected in the oral epithelium and in cells of the underlying connective tissue in periodontitis tissue, and BAFF protein was increased in the serum of periodontitis patients.Conclusion: Periodontal resident cells express BAFF during periodontal inflammation and participate in providing a favorable milieu for the survival and action of B cells.

1 January 2026 in Aging and disease
Verified
Journal Article
Open access
PDF file
EKElin Kindstedt
Elin Kindstedt
MWMagnus Wänman
Magnus Wänman
WWWendy Yi-Ying Wu
Wendy Yi-Ying Wu
KHKlara Hofer-Mattsson
Klara Hofer-Mattsson
ALAnna Lövgren
Anna Lövgren
PLPernilla Lundberg
Pernilla Lundberg
Systemic dissemination of inflammation-related proteins has been linked to unhealthy ageing and increased mortality. Yet, the systemic inflammatory profile of periodontitis, a common oral inflammatory disease, remains poorly characterised. The aim of this study was to evaluate the existing evidence linking alterations in serum levels of inflammation-related proteins to periodontitis. This study was registered in Prospero (CRD42024597308). The inclusion criteria were original, English language studies of human participants ≥16 years that assessed serum biomarkers in individuals with periodontitis and periodontally healthy controls. PubMed, Scopus, and Web of Science were searched on October 13, 2024, and complemented with a hand search. Two independent reviewers performed abstract screening, full-text assessment, risk-of-bias assessment (modified Newcastle-Ottawa Scale), and extraction of summary data. A random-effects meta-analysis was performed to estimate the ratio of mean protein (RoM) level between periodontitis cases and controls. From 9120 screened records, 206 studies were included in the qualitative data synthesis, yielding 17953 participants (157 unique proteins) in total. Data from 144 studies (39 proteins) were included in the meta-analysis. In individuals with periodontitis compared with controls, analyses showed significantly (P<0.05) higher levels of C-C motif chemokine ligand 2 (CCL2); interleukin (IL)-1β, IL-6, IL-17, IL-17A and IL-18; leptin; matrix metalloproteinase 8 (MMP-8), myeloperoxidase (MPO); receptor activator of nuclear factor kappa-Β ligand (RANKL); and tumour necrosis factor α (TNF-α). Notably, CCL2, IL-1β, IL-6, IL-17, IL-17A, MMP-8, RANKL and TNF-α remained significantly elevated even in analyses restricted to systemically healthy participants, with additional significant associations observed for IL-12 and IL-33. Periodontitis is, independently of comorbidities, associated with systemic inflammation and with specific cytokines involved in metabolic and immune dysregulation, including inflammaging. These findings highlight the systemic impact of periodontitis and the importance of reducing the inflammatory burden to promote healthy aging and longevity.

24 June 2022 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
SRSara Rosendahl
Sara Rosendahl
RSRima Sulniute
Rima Sulniute
JPJulia Persson
Julia Persson
SFSebastian Forsberg
Sebastian Forsberg
RHRebecka Häggvik
Rebecka Häggvik
PLPernilla Lundberg
Pernilla Lundberg
We recently showed that adult male mice that lacked the C-C-chemokine receptor 3 (CCR3) exhibited disturbed bone remodeling, which resulted in a cortical bone phenotype of thin femoral cortical bone. However, it remains unknown whether this phenotype would be present during bone modeling, or it affects female mice. Here, we analyzed juvenile and adolescent CCR3-deficient mice to determine when bone modeling was affected in the absence of CCR3 signaling. To investigate whether the CCR3 bone phenotype was sex-related, we analyzed both young female and male mice, and adult females. Micro-computed tomography (μCT) and histomorphometric analyses in adolescent CCR3-deficient male mice revealed reduced cortical bone volume and thickness, and an increase in periosteal mineralization. Interestingly, no skeletal phenotype was observed in adolescent or adult female CCR3-deficient mice. Among juvenile CCR3-deficient mice, neither males nor females showed a skeletal phenotype, which indicated that bone modeling was not affected by the CCR3 deficiency. In summary, adolescent and adult male mice that lacked CCR3 receptors exhibited a cortical phenotype that was not present in female mice, probably due to an estrogen protective mechanism. Based on these and our previous results, we suggest that the importance of CCR3 in cortical bone turnover is related to sex hormones. Because only a few molecules are known to control cortical bone turnover, our novel finding that CCR3 regulated cortical bone thickness only in males suggested that CCR3 is a novel target for controlling cortical bone morphology in male individuals, and perhaps, in post-menopausal women.